INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🔴 Indaptus Therapeutics is trading 10.42% down as global risk-off sentiment pressures shares
Indaptus Therapeutics is trading at $2.32, down 10.42%, as broad risk-off sentiment weighs on markets. - Major U.S. indices are lower amid rising yields, oil...
🔴 Indaptus Therapeutics is trading 8.24% down today amid broader equity and biotech pressure
Indaptus Therapeutics is trading 8.24% down at $2.38, with the decline consistent with broader equity and biotech weakness; no fresh company-specific catalyst...
🟢 Indaptus Therapeutics is trading 5.46% up
Indaptus Therapeutics is trading at $2.51, up 5.46%, with no verified catalyst identified for the move. - No verified company announcement or confirmed...
🔴 Indaptus Therapeutics is trading 5% down
Indaptus Therapeutics is trading 5.04% lower at $2.26, with no verified October 5 announcement or confirmed catalyst explaining the decline. - The latest...
🟢 Indaptus Therapeutics is trading 9.24% up in pre-market
Indaptus Therapeutics is trading at $2.60, up 9.24% in pre-market, with no clear catalyst identified. - No verified October 5 company announcement was found;...
🟢 Indaptus Therapeutics is trading 11% up today amid broader market rally; no company-specific catalyst identified
Indaptus Therapeutics is trading 10.61% up at $2.35 amid a broad market rally, though no direct cause for its move has been confirmed. - No verified...
🟢 Indaptus Therapeutics is trading 5.66% up today with no company-specific catalyst identified
Indaptus Therapeutics is trading at $2.24, up +5.66%, with no verified company-specific announcement explaining the October 2 move; broader market gains may be...
🔴 Indaptus Therapeutics is trading 8.25% down with no clear catalyst identified
Indaptus Therapeutics is trading 8.25% down at $1.95 on October 2, 2026, with no verified company-specific announcement explaining the move. - Shares closed...
🔴 Indaptus Therapeutics is trading 7.2% down
Indaptus Therapeutics is trading 7.17% lower at $2.13, with no specific company announcement identified to explain the October 1 move. - The pullback extends...
🔴 Indaptus Therapeutics is trading 11% down as the reason remains unclear
Indaptus Therapeutics is trading 10.88% down at $2.54, with no clear reason identified for the September 30 decline. - Shares fell 13.37% on September 29 and...
🟢 Indaptus Therapeutics is trading 7% up in pre-market with no clear catalyst identified
Indaptus Therapeutics is trading at $3.05, up 7.02%, with no clear company-specific news explaining the September 30 pre-market gain. - The latest identified...
🟢 Indaptus Therapeutics is trading 8.07% up in after-hours trading with no clear catalyst identified
Indaptus Therapeutics is trading 8.07% up at $3.08 in after-hours, with no clear company-specific catalyst identified. - The September 29 regular-session close...
🔴 Indaptus Therapeutics is trading 10.64% down — as no clear catalyst was identified
Indaptus Therapeutics is trading 10.64% lower at $2.94; the specific reason for the September 29, 2026 decline remains unclear. - No clear company-specific...
🔴 Indaptus Therapeutics is trading 6.7% down with no clear company-specific catalyst
Indaptus Therapeutics is trading 6.7% lower at $3.07; no clear company-specific announcement explaining the September 29 move was identified. - Recent...
🟢 Indaptus Therapeutics is trading 9.72% up in after-hours trading with no identified catalyst
Indaptus Therapeutics is trading at $3.61, up 9.72% versus the regular-session close of $3.29; the cause of the after-hours rise is unclear. - No new...
🔴 Indaptus Therapeutics is trading 10.5% down — no new company-specific catalyst identified
Indaptus Therapeutics is trading 10.52% lower at $3.44, with no new company-specific announcement identified to explain the September 28, 2026 decline. - The...
🔴 Indaptus Therapeutics is trading 11% down today with no clear catalyst
Indaptus Therapeutics is trading at $3.56, a -11.00% move, with no clear company-specific announcement explaining the September 25, 2026 decline. - The...
🔴 Indaptus Therapeutics is trading 6.25% down today with no clear company-specific catalyst
Indaptus Therapeutics is trading 6.25% down at $3.75, with no clear company-specific catalyst identified for September 25, 2026. - The previously announced...
🟢 Indaptus Therapeutics is trading 6.63% up today; catalyst remains unclear
Indaptus Therapeutics is trading 6.63% higher at $4.02, with no company-specific announcement or regulatory catalyst identified for September 24, 2026. - The...
🟢 Indaptus Therapeutics is trading 5.84% up in pre-market as XBI gains 2.61%
Indaptus Therapeutics is trading 5.84% higher at $3.99 in pre-market, primarily supported by stronger biotech sentiment, with XBI up 2.61%. - Shares closed at...